CervoMed Inc (NASDAQ:CRVO) price on Thursday, March 20, rose 23.37% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.56.
A look at the stock’s price movement, the close in the last trading session was $9.37, moving within a range at $9.34 and $12.27. Turning to its 52-week performance, $26.38 and $1.80 were the 52-week high and 52-week low respectively. Overall, CRVO moved 402.61% over the past month.
CervoMed Inc’s market cap currently stands at around $100.60 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-16.
Analysts have a consensus estimate of 1.96M for the company’s revenue for the quarter, with a low and high estimate of 1.2M and 3.01M respectively. The average forecast suggests down to a -16.41% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 5.61M, representing a -42.36% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CRVO is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend CRVO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CRVO’s current price about 167.58% and 278.05% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 93.68, while 7-day volatility ratio is 24.67% and 21.93% in the 30-day chart. Further, CervoMed Inc (CRVO) has a beta value of 0.39, and an average true range (ATR) of 1.06. Analysts have given the company’s stock an average 52-week price target of $16.32, forecast between a low of $16.32 and high of $19.29. Looking at the price targets, the low is -41.18% off current price level while to achieve the yearly target high, price needs to move -66.87%. Nonetheless, investors will most likely welcome a -41.18% jump to $16.32 which is the analysts’ median price.
If we refocus on CervoMed Inc (NASDAQ:CRVO), historical trading data shows that trading volumes averaged 25.76 over the past 10 days and 4.43 million over the past 3 months. The company’s latest data on shares outstanding shows there are 8.70 million shares.
The 35.20% of CervoMed Inc’s shares are in the hands of company insiders while institutional holders own 17.08% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.9 million on 2025-02-28, giving us a short ratio of 10.62. The data shows that as of 2025-02-28 short interest in CervoMed Inc (CRVO) stood at 1691.0 of shares outstanding, with shares short falling to 1.04 million registered in 2025-01-31. Current price change has pushed the stock 394.02% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CRVO stock continues to rise going into the next quarter.
